Market Cap

ClearPoint Neuro, Inc. Market Capitalization:

$417.4 Million

USD as of Jan. 1, 2026

business ClearPoint Neuro, Inc. Company Profile

ClearPoint Neuro, Inc. Main Stock Listing

NASDAQ: CLPT

Market Capitalization History of ClearPoint Neuro, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Devices
Company Market Cap (USD)
Abbott $216.15 B
Boston Scientific Corporation $140.40 B
Stryker $133.15 B
Medtronic $123.20 B
Edwards Lifesciences Corporation $50.10 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of ClearPoint Neuro, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $417.4 M -15.24%
Jan. 1, 2025 $492.4 M 228.39%
Jan. 1, 2024 $149.9 M -42.74%
Jan. 1, 2023 $261.9 M 10.87%
Jan. 1, 2022 $236.2 M -62.63%
Jan. 1, 2021 $632.1 M 354.42%
Jan. 1, 2020 $139.1 M 100.00%
Jan. 1, 2019 $69.5 M -13.33%
Jan. 1, 2018 $80.2 M 11.94%
Jan. 1, 2017 $71.7 M -82.82%
Jan. 1, 2016 $417.3 M -48.00%
Jan. 1, 2015 $802.5 M -44.85%
Jan. 1, 2014 $1.46 B -19.05%
Jan. 1, 2013 $1.80 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

ClearPoint Neuro, Inc. Categories

United States languages Healthcare languages Medical Devices
United States Healthcare United States Medical Devices

Stocks & Indices

ClearPoint Neuro, Inc. has the following listings and related stock indices.


Stock: NASDAQ: CLPT

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.